Joint AASLD/IDSA practice recommendations reflect new data on prevention, treatment, and surveillance of chronic hepatitis B, ...

A new research study shows that hepatitis B vaccination rates among newborns in the U.S. declined by more than 10 percent ...

Detectable serum HBV RNA in chronic hepatitis B patients with undetectable viral DNA was associated with a 3.2-fold higher ...

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...

Read more about how a dive in HBV rates in infants in the USA has undone years of steady increase in vaccination uptake.

At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches.

Researchers at Hiroshima University and Gifu Kyoritsu University identified Hepatitis B RNA serum levels as a biomarker that more accurately ...

Newborn hepatitis B virus vaccination rates in the U.S. decreased by over 10 percentage points in the last 2 years after ...

Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.

The Supreme Court sought detailed information on the costs and availability of conducting Nucleic Acid Amplification Testing ...

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...

Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively ...